MedTrace Logo

Effect of a Probiotic on Visceral Fat Accumulation

NCT02921217 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 129

Last updated 2016-10-03

No results posted yet for this study

Summary

The study's main objective is to investigate if an extract containing the probiotic Bifidobacterium animalis subsp. lactis BPL1 (CECT 8145) has a positive effect on the accumulation of abdominal visceral fat in people with abdominal obesity.

Conditions

  • Obesity
  • Intra-Abdominal Fat
  • Subcutaneous Fat, Abdominal

Interventions

DIETARY_SUPPLEMENT

Active Probiotic

Product 1: 200 mg maltodextrin and 100 mg of active Bifidobacterium animalis subsp. lactis BPL1 (CECT 8145) (1011 CFU/g),

DIETARY_SUPPLEMENT

Inactivated probiotic

Product 1: 200 mg maltodextrin and 100 mg of Bifidobacterium animalis subsp. lactis BPL1 (CECT 8145) inactivated by heat (1011 CFU/g),

DIETARY_SUPPLEMENT

Control

Placebo: 300 mg maltodextrin.

Sponsors & Collaborators

  • Technological Centre of Nutrition and Health

    collaborator OTHER

  • Hospital Universitari Sant Joan de Reus

    collaborator OTHER

  • University Rovira i Virgili

    collaborator OTHER

  • Biopolis S.L.

    lead INDUSTRY

Principal Investigators

  • Rosa Solà, Prof. MD · University Rovira i Virgili / Hospital Universitari Sant Joan de Reus

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2017-05-31
Completion
2017-08-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02921217 on ClinicalTrials.gov